Brief: Compass Pathways And Journey Clinical Establish Research Collaboration Agreement
29/04/2024 12:22
April 29 (Reuters) - Compass Pathways PLC CMPS.O :
* COMPASS PATHWAYS AND JOURNEY CLINICAL ESTABLISH RESEARCH
COLLABORATION AGREEMENT TO INFORM THE TRAINING OF HEALTHCARE
PROVIDERS AND DELIVERY MODEL FOR COMP360 PSILOCYBIN TREATMENT,
IF APPROVED FOR TREATMENT-RESISTANT DEPRESSION
Source text for Eikon: ID:nGNX6K9c80
Further company coverage: CMPS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on COMPASS Pathways
See all newsBrief: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
UK's Compass Pathways Q1 operating income beats estimates as expenses fall
Health Rounds: Researchers gain new insight into how psychedelics affect the brain
U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications